Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sonoma Pharmaceuticals (SNOA) Short term Debt: 2011-2012

Historic Short term Debt for Sonoma Pharmaceuticals (SNOA) over the last 2 years, with Dec 2012 value amounting to $1.1 million.

  • Sonoma Pharmaceuticals' Short term Debt rose 20.13% to $1.1 million in Q4 2012 from the same period last year, while for Dec 2012 it was $1.1 million, marking a year-over-year increase of 20.13%. This contributed to the annual value of $1.4 million for FY2012, which is 56.01% up from last year.
  • Per Sonoma Pharmaceuticals' latest filing, its Short term Debt stood at $1.1 million for Q4 2012, which was down 26.93% from $1.6 million recorded in Q3 2012.
  • In the past 5 years, Sonoma Pharmaceuticals' Short term Debt registered a high of $1.6 million during Q3 2012, and its lowest value of $804,000 during Q2 2011.
  • For the 2-year period, Sonoma Pharmaceuticals' Short term Debt averaged around $1.1 million, with its median value being $1.0 million (2011).
  • Data for Sonoma Pharmaceuticals' Short term Debt shows a peak YoY soared of 84.20% (in 2012) over the last 5 years.
  • Over the past 2 years, Sonoma Pharmaceuticals' Short term Debt (Quarterly) stood at $944,000 in 2011, then climbed by 20.13% to $1.1 million in 2012.
  • Its Short term Debt stands at $1.1 million for Q4 2012, versus $1.6 million for Q3 2012 and $1.5 million for Q2 2012.